β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
US10202412B2 · kind B2 · utility
2Cited by
83References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2017 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Jul 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/207
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to a virus of the Paramyxoviridae or Orthomyxoviridae family, or other disorders, in particular respiratory syncytial virus, more fully described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.